Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages

  Han, Seung Jin ^a,b   Kim, Hae Jin ^a   Choi, Sung E ^a   Kang, Yup ^a   Lee, Kwan Woo ^a   Kim, Dae Jung ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

GLP 1; Incretin; Type 2 diabetes

Indexed keywords

C PEPTIDE; DIPEPTIDYL PEPTIDASE IV; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SOUTH KOREA;

EID: 77955418384     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.06.004     Document Type: Article

References (15)

1. Nauck M., Stockmann F., Ebert R., Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986, 29:46-52.
2. Toft-Nielsen M.B., Damholt M.B., Madsbad S., Hilsted L.M., Hughes T.E., Michelsen B.K., et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 2001, 86:3717-3723.
3. Vilsboll T., Krarup T., Deacon C.F., Madsbad S., Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001, 50:609-613.
4. Muscelli E., Mari A., Casolaro A., Camastra S., Seghieri G., Gastaldelli A., et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008, 57:1340-1348.
5. Vollmer K., Holst J.J., Baller B., Ellrichmann M., Nauck M.A., Schmidt W.E., et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008, 57:678-687.
6. Knop F.K., Vilsboll T., Hojberg P.V., Larsen S., Madsbad S., Volund A., et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?. Diabetes 2007, 56:1951-1959.
7. Ryskjaer J., Deacon C.F., Carr R.D., Krarup T., Madsbad S., Holst J., et al. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 2006, 155:485-493.
8. Lee S., Yabe D., Nohtomi K., Takada M., Morita R., Seino Y., et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J 2010, 57:119-126.
9. Kozawa J., Okita K., Imagawa A., Iwahashi H., Holst J.J., Yamagata K., et al. Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes. Biochem Biophys Res Commun 2010, 393:410-413.
10. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
11. Kim D.J., Lee M.S., Kim K.W., Lee M.K. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism 2001, 50:590-593.
12. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001, 24:539-548.
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
14. Carr R.D., Larsen M.O., Jelic K., Lindgren O., Vikman J., Holst J.J., et al. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocrinol Metab 2010, 95:872-878.
15. Xu G., Kaneto H., Laybutt D.R., Duvivier-Kali V.F., Trivedi N., Suzuma K., et al. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 2007, 56:1551-1558.